Echoes of Liver in the Lung: A Diagnostic Zebra in Thoracic Oncology

Hepatoid adenocarcinoma (HAC) is a rare and aggressive subtype of extrahepatic adenocarcinoma that mimics hepatocellular carcinoma. Pulmonary HAC is exceptionally uncommon and often presents diagnostic and therapeutic challenges. We describe a 65-year-old woman with chronic obstructive pulmonary disease and hypertension who presented with progressive dyspnea. Imaging revealed right lung masses and mediastinal lymphadenopathy. Biopsy confirmed hepatoid non–small cell lung cancer. Molecular testing revealed no actionable mutations. The patient declined systemic therapy. This case highlights the complexity of managing pulmonary HAC, the role of shared decision making, and the urgent need for more evidence-based treatment approaches.

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine Clinical Cases
Published
2025-10-01
DOI
https://doi.org/10.7326/aimcc.2025.0695
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Echoes of Liver in the Lung: A Diagnostic Zebra in Thoracic Oncology

Emily Chen, Irene Pokuaa, Nasim Salimiaghdam, Ahmed Mustafa et al.
Annals of Internal Medicine Clinical Cases
Lung Cancer Diagnosis and Treatment
article

Echoes of Liver in the Lung: A Diagnostic Zebra in Thoracic Oncology

Emily Chen, Irene Pokuaa, Nasim Salimiaghdam, Ahmed Mustafa, Afshin Hamidi
article en

Abstract

Hepatoid adenocarcinoma (HAC) is a rare and aggressive subtype of extrahepatic adenocarcinoma that mimics hepatocellular carcinoma. Pulmonary HAC is exceptionally uncommon and often presents diagnostic and therapeutic challenges. We describe a 65-year-old woman with chronic obstructive pulmonary disease and hypertension who presented with progressive dyspnea. Imaging revealed right lung masses and mediastinal lymphadenopathy. Biopsy confirmed hepatoid non–small cell lung cancer. Molecular testing revealed no actionable mutations. The patient declined systemic therapy. This case highlights the complexity of managing pulmonary HAC, the role of shared decision making, and the urgent need for more evidence-based treatment approaches.

Annals of Internal Medicine Clinical CasesVol. 4(10)
Arrowhead Regional Medical Center (US), Inova Fairfax Hospital (US), Regional Medical Center (US), Capital Health (US)
Openalex Percentile: Top 60%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.